Beta Bionics (BBNX) Cash & Current Investments (2023 - 2026)

Beta Bionics' Cash & Current Investments history runs 4 years deep, the most recent figure standing at $30.3 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 86.91% year-over-year to $30.3 million; the TTM figure through Mar 2026 stood at $30.3 million (down 86.91% YoY), while the FY2025 annual figure was $219.1 million, up 111.56% from the prior year.
• Cash & Current Investments came in at $30.3 million for Q1 2026 at Beta Bionics, down from $219.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $249.7 million in Q2 2025 to a low of $13.0 million in Q2 2024.
• A 4-year average of $121.2 million and a median of $100.2 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments jumped 1816.65% in 2025 and sank 86.91% in 2026, its largest moves.
• Beta Bionics' Cash & Current Investments stood at $96.7 million in 2023, then advanced by 7.06% to $103.6 million in 2024, then soared by 111.56% to $219.1 million in 2025, then slumped by 86.17% to $30.3 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $30.3 million, $219.1 million, and $228.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison